Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes

Clinical Endocrinology

Volumn 79, Issue 2, 2013, Pages 204-210

  Obata, Yoshinari ^a   Yamada, Yuya ^a   Takahi, Yasumitsu ^a   Baden, Megu Y ^a   Saisho, Kenji ^a   Tamba, Sachiko ^a   Yamamoto, Koji ^a   Umeda, Miyuki ^a   Furubayashi, Aiko ^a   Matsuzawa, Yuji ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPENDENT VARIABLE; DIABETIC PATIENT; DISEASE ASSOCIATION; EXPLANATORY VARIABLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84880049542     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12041     Document Type: Article

References (35)

1. Maeda, K., Okubo, K., Shimoura, I., et al,. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications, 221, 286-289.
2. Diez, J.J., &, Iglesias, P., (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
3. Ouchi, N., &, Walsh, K., (2007) Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta, 380, 24-30.
4. Nedvidkova, J., Smitka, K., Kopsky, V., et al,. (2005) Adiponectin, an adipocyte derived protein. Physiological Research, 54, 133-140.
5. Li, S., Shin, H.J., Ding, E.L., et al,. (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association, 302, 179-188.
6. Adamczak, M., Wiecek, A., Funahashi, T., et al,. (2003) Decreased plasma adiponectin concentration in patients with essential hypertension. American Journal of Hypertension, 16, 72-75.
7. Matsubara, M., Maruoka, S., &, Katayose, S., (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. The Journal of Clinical Endocrinology and Metabolism, 87, 2764-2769.
8. Tamba, S., Nishizawa, H., Funahashi, T., et al,. (2008) Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Internal Medicine, 47, 1175-1180.
9. Baden, M.Y., Yamada, Y., Obata, Y., et al,. (2011) Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities. Nutrition and Diabetes, 13, doi: 10.1038/nutd.2011.13.
10. Baden, M.Y., Yamada, Y., Takahi, Y., et al,. (2012) Association of adiponectin with blood pressure in healthy people. Clinical Endocrinology, 22, doi: 10.1111/j.1365-2265.2012.04370.x.
11. Ai, M., Otokozawa, S., Asztalos, B.F., et al,. (2011) Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis, 217, 543-548.
12. Arita, Y., Kihara, S., Ouchi, N., et al,. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
13. Yasumichi, A., Susumu, N., Toshio, K., et al,. (2006) High adiponectin concentration and its role for longevity in female centenarians. Geriatrics and Gerontology International, 6, 32-39.
14. Cnop, M., Havel, P.J., Utzschneider, K.M., et al,. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46, 459-469.
15. Adamczak, M., Rzepka, E., Chudek, J., et al,. (2005) Ageing and plasma adiponectin concentration in apparently healthy males and females. Clinical Endocrinology, 62, 114-118.
16. Isobe, T., Saitoh, S., Takaqi, S., et al,. (2005) Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. European Journal of Endocrinology, 153, 91-98.
17. Koh, S.J., Hyun, Y.J., Choi, S.Y., et al,. (2008) Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clinica Chimica Acta, 389, 45-50.
18. Kruger, I.M., Huisman, H.W., &, Schutte, A.E., (2011) The relationship between adiponectin, ageing and renal function in a bi-ethnic sample. Requlatory Peptides, 169, 58-63.
19. Cohen, S.S., Gammon, M.D., Signorello, L.B., et al,. (2011) Serum adiponectin in relation to body mass index and other correlates in black and white women. Annals of Epidemiology, 21, 86-94.
20. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. (2010) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Journal of the Japan Diabetes Society, 53, 450-467 (Article in Japanese).
21. Maeda, N., Takahashi, M., Funahashi, T., et al,. (2001) PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 50, 2094-2099.
22. Japanese Society of Nephrology. (2009) Evidence-based practice guideline for the treatment of CKD. Clinical and Experimental Nephrology, 13, 537-566.
23. Nishimura, A., &, Sawai, T., (2006) Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clinica Chimica Acta, 371, 163-168.
24. Komura, N., Kihara, S., Sonoda, M., et al,. (2008) Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circulation Journal, 72, 23-28.
25. Hotta, K., Funahashi, T., Arita, Y., et al,. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis Thrombosis and Vascular Biology, 20, 1595-1599.
26. Furuhashi, M., Ura, N., Higashiura, K., et al,. (2003) Blockade of the renin-angiotensin system increases adiponectin concentration in patients with essential hypertension. Hypertension, 42, 76-81.
27. Nezu, U., Tsunoda, S., Yoshimura, H., et al,. (2010) Pravastatin potentiates increases in serum adiponectin concentration in dyslipidemic patients receiving thiazolidinedione: the DOLPHIN study. Journal of Atherosclerosis and Thrombosis, 17, 1063-1069.
28. Zoccali, C., Mallamaci, F., Tripepi, G., et al,. (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology, 13, 134-141.
29. Imagawa, A., Funahashi, T., Nakamura, T., et al,. (2002) Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care, 25, 1665-1666.
30. George, J., Patal, S., Wexler, D., et al,. (2006) Circulating adiponectin concentrations in patients with congestive heart failure. Heart, 92, 1420-1424.
31. Hazzard, W.R., &, Ettinger W.H. Jr, (1995) Aging and atherosclerosis: changing considerations in cardiovascular disease prevention as the barrier to immortality is approached in old age. American Journal of Geriatric Cardiology, 4, 16-36.
32. Komura, N., Kihara, S., Sonoda, M., et al,. (2010) Increment and impairment of adiponectin in renal failure. Cardiovascular Research, 86, 471-477.
33. Hosokawa, Y., Yamada, Y., Obata, Y., et al,. (2012) Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients. Clinical and Experimental Nephrology, 16, 399-405.
34. Bottner, A., Kratzsch, J., Muller, G., et al,. (2004) Gender difference of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. The Journal Clinical Endocrinology and Metabolism, 89, 4053-4061.
35. Mori, I., Ishizuka, T., Morita, H., et al,. (2008) Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circulation Journal, 72, 1680-1684.